Genotype-phenotype relationships are determinants of human diseases. Often, we know little about why so many genes are involved 19 in complex common diseases. We hypothesized that this multigene effect arises from the relationship between genes and physiological 20 dynamics. We tested this hypothesis for arrhythmias as physiological dynamics define this disease. We integrated graph theory 21 analysis of genomic and protein-protein interaction networks with dynamical models of ion channel function to identify the 22
physiological dynamics of genome wide variation for five different arrhythmias. Regulatory networks for the cardiac conduction 23 system and arrhythmias were constructed from GWAS and known disease genes. Electrophysiological models of myocyte action 24 potentials were used to conduct extensive parameter variations to identify robust and fragile kinetic parameters that were then, using 25 regulatory networks, associated with genomic determinants. We find that genome-wide determinants of arrhythmias that represent 26 many cellular processes are selectively associated with fragile physiological dynamics of ion channel kinetics. This association 27 predicts disease propensity. Deep RNA sequencing from human left ventricular tissue of arrhythmia and control subjects confirmed 28 the predictive relationship. Taken together these studies show that the varied multigene effects of arrhythmias arises because of 29 associations with fragile kinetic parameters of cardiac electrophysiology. 30 31 32 33 Significance Statement: 34 Our understanding of the genetics of common diseases has advanced exponentially over the past decade. We now know that 35 differences and variation in multiple genes contribute to disease susceptibility with significant heterogeneity in the phenotype. 36 However, how genetic variation contributes to disease phenotypes remains unknown. We hypothesized that the relationships between 37 physiological dynamics and genetic architecture is a fundamental determinant of disease susceptibility and genetic heterogeneity. To 38 test our hypothesis, we integrated mathematical models of cardiac electrophysiology with genetic network models of cardiac 39 arrhythmias. We found that disease related genome variants were selectively associated with fragile kinetic parameters that predict 40 disease propensity and identified several novel cellular processes associated with arrhythmogenesis. 41 INTRODUCTION 43 The genetic architecture of many common diseases has been extensively studied over the past decade providing 44 valuable insight into the etiology of disease (1, 2) . Differences and variation in genetic architecture contribute to 45 disease susceptibility (1) (2) (3) (4) . Despite tremendous advances in the genetic basis of these diseases our 46 understanding of how and why genomic changes manifest as disease phenotype remains incomplete and our 47 ability to predict disease risk is often inadequate. This is especially true for many complex progressive diseases 48 including autoimmune disorders, neuropsychiatric diseases, diabetes and cardiovascular diseases. The 49 relationships between genotype and phenotype are complex because they are based on genetic heterogeneity, 50 the environment and the dynamics of physiology resulting in nonlinear interactions between genes and gene 51 products (1, 2, (5) (6) (7) . We sought to identify a simple principle as to why so many varied genomic determinants 52 are involved in disease phenotype. We hypothesized that the involvement could be due to a selective association 53 with fragile features of the physiological dynamics. To test this hypothesis we used a model integration 54 approach combining network models with multi-compartment ODE models. 55 Arrhythmias are complex diseases that most often arise from mutations in genes that encode ion 56 channels ultimately leading to altered physiological dynamics. Nevertheless, recent evidence suggests that 57 drivers of conduction abnormalities and arrhythmias can extend well beyond mutated channel proteins. For 58 example, Wnt11 has been associated with the ECG PR interval in GWAS (8) and in a separate study was shown 59 to pattern a myocardial electrical gradient through regulation of the L-type Ca 2+ channel (9) . Similarly, the 60 transcription factor PITX2, has been associated with atrial fibrillation in GWAS (10) and was subsequently 61 shown to regulate ion transport and impair calcium handling (11, 12) . A multi-model approach that integrates 62 physiological dynamics, cell regulatory networks and genetic architecture could provide insight as to why such 63 varied genes are involved. Using canonical cell biological knowledge it is possible to schematically describe the 64 relationships between cell regulatory networks to cardiac myocyte action potentials and consequently to 65 conduction abnormalities. To mechanistically connect genomic variations to physiological dynamics we need to 66 integrate two types of computational models: (1) network models that delineate the topology of regulation in 67 terms of gene products (proteins) and their interactions and (2) dynamical models that describe the time course 68 of physiological responses (i.e. ion channel function) in terms of protein function. Both types of models have 69 been used to study arrhythmias. Previous network analysis studies have shown considerable overlap in the 70 human interactome between products of genes that can cause Long QT syndrome when mutated and targets of 71 drugs that can cause adverse cardiac events (13, 14) . This analysis generated the prediction, subsequently 72 validated by clinical observations, that loperamide could cause arrhythmias (15). A different computational 73 approach, combining statistical regression analysis with dynamical models of cardiac electrophysiology, at the 74 cellular and organ levels, also provided deep insight into the quantitative dynamic relationship between the 75 cardiomyocyte action potential and the heart's electrical activity (16 To test our hypothesis that disease related genes might associate with the fragile features of 82 physiological dynamics we integrated the network and dynamical models. We found that disease related 83 genome variants were selectively associated with fragile kinetic parameters. Model integration also identified 84 several cellular processes that could be associated with arrhythmogenesis. Using deep RNA sequencing data 85 from human cardiac tissue from patients with arrhythmias we verified many key predictions from our integrated 86 model including an association of arrhythmias with fragile kinetic parameters and the involvement of pathways 87 such as propanoate metabolism. We combined multiscale data with unsupervised learning to identify genomic 88 determinants of disease that correlate with fragile genes allowing us to demonstrate why genes belonging to 89 many cellular processes are associated with increased disease propensity. 
RESULTS
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We studied the systems biology of arrhythmias through integration of graph theory and dynamical modeling, 93 combined with transcriptomic analysis of human heart tissue, to better understand how genomic architecture 94 can contribute to cardiac electrical phenotypes. Figure 1 shows a schematic of the computational and 95 experimental methods used in this study. Initially, we compiled prior information from classical disease gene 96 discovery and GWA studies to comprehensively catalog genomic determinants, including mutations, SNPs and 97 other genomic variants, known to be associated with ECG characteristics and five types of arrhythmias. This 98 database of genes was then used to build protein-protein interaction networks and identify potential novel 99 disease mechanisms. Next, we used well known ordinary differential equation based models of the 100 cardiomyocyte action potential to identify parameters (kinetic properties of gene products) that were either 101 sensitive (fragile) or robust to modulation. Our approach surprisingly identified that fragile kinetic parameters 102 are preferentially associated with disease related genomic determinants. The network analysis also generated the 103 unexpected prediction that arrhythmia genes are closely associated with genes involved in previously unrelated 104 cellular processes, including propanoate metabolism, the ubiquitin proteasomal degradation pathway, and 105 histone modification and chromatin remodeling. We then validated numerous predictions from our models 106 using transcriptomic profiling of human left ventricular tissue from patients with arrhythmias. 107 108 109 We utilized published human studies to identify all known genes associated both with the ECG and five 110 different arrhythmias: atrial fibrillation, QT-Opathies, Brugada, catecholaminergic polymorphic ventricular 111 tachycardia (CPVT) and progressive cardiac conduction defect (PCCD) ( Supplementary Fig. 1a-b ). We Supplementary Figure 2 . 124 Using genes associated with particular arrhythmias and ECG characteristics as seed nodes, we 125 developed biological interaction networks by expanding around these nodes using protein-protein interactions 126 (26, 27) . Networks were constructed using direct protein interactions with seed genes and one intermediate node 127 to connect the seed nodes. In the Supplementary Materials Section we describe the databases from which 128 human protein interactions were imported and the methods used to expand ECG and arrhythmia network genes 129 to 4190 and 4955 components, respectively. Representative networks for five separate arrhythmias and 130 components of the ECG are shown in Supplementary Figure 3 . 131 Atrial fibrillation is the most common human cardiac arrhythmia with a rapidly increasing prevalence 132 and incidence worldwide. The atrial fibrillation network is shown in Figure 2a with several highlighted clusters 133 of densely connected nodes identified based on connectedness and biological function. For example, the cluster 134 of red nodes (genes) in the top right corner of Figure 2 is enriched for genes involved in propanoate metabolism. 135 Functional gene enrichment of each arrhythmia network was used to identify biological processes potentially 136 contributing to disease. Overrepresented gene ontology terms were determined from lists of genes that make up 137 each network (28). Figure 2b shows a functional enrichment network of the most significant biological 138 processes involved with atrial fibrillation. Nodes in the enrichment network indicate the most over-represented 139 biological processes, with node size scaled using the betweeness centrality and color coded according to the 140 biological process (metabolism, histone modification, etc.) . Edges between nodes, with thickness scaled using 141 edge betweeness, indicate that multiple genes contribute to each process. For example, genes within the atrial 142 fibrillation network that are involved with Wnt signaling also contribute to heart development, chromatin 143 modification and androgen signaling, among others. Supplementary Table 3 summarizes the most significant 144 enrichment terms used to describe the set of network genes for all five arrhythmias. 145 The biological functions of genes contributing to the arrhythmia networks can be classified into seven 146 major groups; cellular signaling, transport (including ion channels), metabolism, protein turnover, gene 147 expression, chromatin and histone modifications, and development. The similarities and differences between 148 arrhythmia networks were identified and categorized for each of the seven major groupings (Supplementary 149   Table 3 ). Significant overlap of enriched biological processes from genes involved with arrhythmias was found. 150 This analysis revealed several cellular processes that have not been previously associated with 151 arrhythmogenesis. For example, RNA splicing, ubiquitin degradation, membrane transport and metabolism, 152 more specifically propanoate metabolism, were all enriched in multiple arrhythmia networks. The network 153 models therefore generate potentially testable hypotheses by suggesting that these biological processes may be 154 related to the pathophysiology of arrhythmias. Although the expanded networks most certainly contain some 155 genes that do not contribute to disease it is less likely that these "non-disease" genes will be identified as highly 156 enriched or components of highly connected dense clusters. Furthermore, we verified many of the biological 157 processes identified in the networks using human RNA sequencing and functional knockdown experiments in 158 zebrafish.
Networks from ECG and arrhythmia genomic determinants identify new biological associations
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The macro-scale topology of arrhythmia networks shows well-connected communities linked to more 160 isolated communities. Each network is defined by a number of dense communities or hubs connected to other 161 regions of the network via less well connected or sparse clusters. The Venn diagrams readily highlight the 162 substantial genetic overlap and number of unique genes between the various ECG and arrhythmia components 163 suggesting a large number of potential disease or modifier genes involved with the cardiac electrical response 164 including the diversity of molecular responses leading to phenotypic heterogeneity. That is, there are many 165 different routes to disease. To further characterize network structure we calculated topological parameters and 166 various network statistics (Supplementary Figures 4-13 ). Both the ECG and arrhythmia networks are 167 approximately scale free with power law like degree distributions (Supplementary Figures 4 and 6) . The 168 degree distributions of these real world genetic interaction ECG and arrhythmia networks systematically and 169 expectedly deviate from the degree distributions of random networks with the same number of nodes and edges 170 ( Supplementary Figures 5 and 7) . To assess global (average) network metrics, we calculated the average 171 clustering coefficient, density, heterogeneity, centralization and characteristic path length of each network 172 ( Supplementary Figures 8 and 9 ) (29). The network statistics confirmed the visual impression that these 173 networks are highly connected, dense and heterogeneous with high degrees of centrality measures as compared 174 to random networks. These findings are expected and suggest that arrhythmia networks comprise a large 175 number of essential disease genes or modifier disease genes with potentially fragile interdependencies (30-32). and well known biological processes. In fact, the overlap of all human RNA seq enrichment terms with the 195 atrial fibrillation network enrichment terms is nearly 70% and greater than 50% overlap is observed with all 196 other arrhythmia networks (Fig. 3d) . 197 198 From topology to dynamics: Mapping the kinetic parameters that contribute to the fragility of dynamics 199 onto genes 200 The topological network and enrichment analyses are useful in understanding at a global level the subcellular 201 processes involved in arrhythmias, however, network models do not provide information about physiological 202 dynamics. Hence we sought to integrate dynamical models of cardiac electrophysiology with the gene 203 interaction network models. This integrated computational analysis can help us ascertain the value of genomic 204 changes in altering physiological responses. The dynamical models identify both fragile and robust genes 205 potentially contributing to disease which may also be useful for predicting disease propensity. 206 Using well-established dynamical models, we conducted massive simulations of atrial, ventricular and 207 SA node cardiac action potentials by systematically varying the parameters that define the conductances and 208 rates of ion transport (16, 18, (33) (34) (35) (36) . Supplementary Figures 14-15 ). To perform pairwise parameter analysis we simultaneously varied two 218 parameters while recording the outputs at the end of the simulation. The magnitude of the regression 219 coefficients from regression analysis are quantitative measures of the sensitivity of simulation outputs (e.g., 220 voltage, calcium transients) to parameter perturbation (e.g., varying L-type Ca 2+ conductance). We also 221 calculated a catastrophic failure score that represents the relative likelihood of a failed action potential due to to perturbation. We defined fragile parameters as those that contribute to nearly 80% of the failures of action 226 potential propagation upon perturbation. Thus the molecular kinetic parameters most sensitive to perturbation 227 are more fragile at a whole cell and organ level as these parameters are more likely to contribute to action 228 potential failure and arrhythmogenesis when perturbed even by a small amount. 229 Our analysis shows that the cardiac action potential is most sensitive to perturbations in the L-type Ca 2+ 230 current (G CaL ), Na + -Ca 2+ exchange current (kNaCa, NCX), and rapid delayed rectifier K + current (G Kr ). The Na + 231 current, Na + -K + pump current (I NaK ) and the cardiac ryanodine receptor channels (RyR) current are also 232 sensitive parameters. The relative importance of each parameter varies according to the model used (SA node, 233 ventricular or atrial AP); however, nearly 80% of the failure scores can be accounted for by sensitivity to 234 perturbation in the aforementioned parameters. Multiparameter sensitivity analysis thus provides a quantitative 235 measure of simultaneous electrophysiological perturbation that can be connected phenomenologically to genes 236 comprising arrhythmia networks and used to help explain phenotypic variation. 237 To determine the relationship between genomic characteristics to electrophysiological dynamics and 238 phenotypes we mapped genes identified in the networks to the sensitive model parameters. Network genes were 239 associated with the dynamical model parameters based on function of the gene and parameter. Supplementary 240 Figure 16 lists some of the important associations between dynamical parameters and network genes. We refer 241 to the nodes that map to the most sensitive parameters as fragile genesthose that, when altered, might result in 242 a greater propensity for developing arrhythmias. An additional network was then constructed connecting 243 dynamical model parameters to genes with the node size scaled to represent parameter fragility and genetic 244 variation obtained from the NCBI databases and Variation Viewer (Fig. 4i) . For example, the Na + -Ca 2+ 245 exchange current, which directly maps to the network node SLC8A1, was shown to be a sensitive parameter 246 from the action potential simulations. Similarly, KCNQ1 and KCNE1, known potassium voltage-gated channel 247 genes required for repolarization, directly map to the slow delayed rectifier K + current parameter, G Ks .
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Human RNA sequencing supports the association of genes with fragile dynamics with arrhythmias 250 Having computationally identified that specific genes involved with arrhythmias have fragile dynamics we 251 sought to test if this computational prediction could be experimentally validated. Fragile dynamics means 252 sensitivity to perturbation and can arise both from variation in kinetic parameters and levels of the reactants. 253 Assuming that mRNA levels could overall reflect protein levels we formulated the hypothesis that fragile genes 254 would show greater changes in disease state or would result in greater changes in other protein levels as a 255 compensatory change. This is in fact how we define sensitive parameters in our dynamical model. Therefore, 256 using human RNA sequencing as our experimental approach and genomic analysis, we sought to determine if 257 this association was valid and identify new mechanisms potentially contributing to disease. In these analyses we 258 also sought to determine the characteristics and potential mechanisms underlying this association. 259 We evaluated human ventricular tissue gene expression profiles of the genes computationally identified 260 to have fragile dynamics in subjects with and without arrhythmias (Figure 4j) . The methods used for RNA 261 sequencing have been previously described (21) and in the Supplementary Materials section. Figure 4j shows 262 the difference in expression of select fragile genes (as a heat map) between subjects with and without 263 arrhythmias, highlighting the substantial changes when a perturbation (human subjects with arrhythmias) is 264 introduced. The Na + -K + ATPase gene has the highest failure score based on the computational ventricular 265 model and also shows one of the highest changes in gene expression in human ventricular tissue in arrhythmia 266 patients. There are considerable differences in expression levels of many genes with fragile dynamics. This data 267 supports our hypothesis that genes with fragile dynamics are likely to show greater changes in their tissue level 268 expression in the disease state. 269 We also used the human RNA expression profiles to further support the association of fragile dynamics 270 with arrhythmia genes by calculating in-vivo robustness and fragility of genes using previously described 271 methods based on variational principles (37). When using human RNA sequencing, fragility can be defined as and novel sequence insertions. We then evaluated the biological function of the most fragile genes that clustered 319 together in the SOMs. The most fragile genes from SOM cluster analysis were multiple genes involved with 320 calcium handling and excitation-contraction coupling (RYR2, CACNA1C, TRDN, CACNA2D1), the rapid 321 delayed rectifier K+ current (KCNQ1, KCNH2) and Na + -Ca 2+ exchange current (ANK2 and SLC8A1). 322 Partial least squares (PLS) regression analysis was used to construct a model that relates genomic 323 architecture and fragility to disease propensity. Disease propensity is the likelihood of developing an arrhythmia 324 based on the failure of propagating an action potential. The PLS model is an independent model that 325 incorporates quantitative information obtained from our dynamical analysis and genomic characteristics to 326 predict disease propensity. Figure 5d shows the relationship between the fragile indices of seed node genes and 327 their disease propensity with the best fit linear surface response shown as a plane (R 2 = 0.96). The x and y axes, 328 labeled as fragile index 1 and 2, are the two scores from the PLS regression analysis which together capture 329 >85% of the variation contained in the 28 different genomic features. The z axis, labeled as disease propensity, 330 represents the failure scores for individual genes derived from the dynamical ODE simulations (Figure 3g-h) . 331 Figure 5e shows the actual disease propensity score vs the fitted disease propensity score from our model (R 2 = 332 0.94) and confirms the three component PLSR model predicts the response well. 333 The SOMs identified and confirm novel fragile genes and the genetic architecture associated with 334 fragility. By looking at the biological function of fragile genes we gain insight to potential disease mechanisms. 335 For example, specific genes involved in metabolism, cellular signaling (e.g., Wnt, Notch, Ca 2+ ), histone and 336 chromatin modification and regulation of RNA splicing also cluster with fragile channel genes. Several of our 337 novel pathway findings were also supported by the literature. For example, multiple clinical trials suggest that 338 histone deacetylase inhibitors and chromatin modulation influences cardiac electrical activity as seen by 339 increased frequency of QT interval prolongation, T wave flattening and atrial fibrillation (38) . HDAC inhibition 340 also has been recently shown to reduce atrial fibrillation and remodeling in dogs (39). 341 We were particularly interested in a specific set of novel fragile genes involved in propanoate and 342 butanoate metabolism that were predicted to influence arrhythmogenesis. At least one study associated inborn 343 errors of metabolism caused by deficiency of propionyl CoA carboxylase with electrophysiological changes 344 including prolongation of the QT interval (40) and two cases report children with propionic acidemia leading to 345 arrhythmias with fatal outcomes (41, 42) . Propanoate metabolism genes possess unique biological functions, 346 network metrics (avg. shortest path length) and also associate with the fragile genes using unsupervised learning 347 methods. Perhaps most importantly, the expression levels of propanoate metabolism genes were significantly 348 different in human subjects with arrhythmias compared to subjects without arrhythmias (Figure 3a) . Their in-349 vivo change in variance in human ventricular tissue also suggests that perturbation of their expression level may 350 contribute to disease (Figure 4k) . These metabolic genes are crucial in amino acid, fatty acid and cholesterol 351 metabolism and many are expressed in the heart and muscle tissues (acetyl-CoA carboxylase), mitochondria 352 (propionyl-CoA carboxylase) and brain tissue, thus contributing to our interest in evaluating their possible link 353 to cardiac disease (43). In addition to the human RNA sequencing data that supports involvement of propanoate 354 metabolism in arrhythmias, we sought to further experimentally test the importance for cardiovascular function 355 using a series of zebrafish knockdown experiments. Morpholinos were used to knock down the propanoate 356 metabolism genes SUCLG1/2, ACACA, PCCA and EHHADH and cardiac phenotypes in zebrafish were 357 characterized using automated microscopic techniques. Supplementary Figure 19 It is now widely accepted that most proteins function as components of networks, and considering their activity 370 in the context of the networks they belong to is useful for understanding how individual protein activities 371 contribute to network based emergent physiological functions. As a network node that is required for dynamic 372 function, a protein within a network needs to be defined by at least two characteristics, its quantity and its 373 ability to interact with its partners. These two characteristics are also the key parameters for the dynamical 374 models: initial concentration of reactant and reaction rate. Thus it should be relatively simple to convert a 375 directed sign-specified network into a system of coupled differential equations and thereby develop a systems 376 level understanding of why some genetic constructs but not others are correlated with disease phenotype. 377 However, our knowledge of protein concentrations and reaction rates is currently sparse, and it is not possible to 378 build reliable dynamical models directly from large network representations. New data integration methods are 379 needed to relate statistical and network representations to parameter values in dynamical models, and this study 380 represents a first step in that direction. 381 When starting the study we had thought that disease determinants would be associated with changes in 382 robust kinetics outside the boundaries of homeostatic tolerance and that these determinants would primarily be 383 coding variants. However, we found that specific types of both non-coding and coding variants in arrhythmia 384 genes were associated with fragile kinetics and correlate with disease propensity. Importantly, our studies show 385 that these multigene effects arise because of the association with fragile kinetic parameters of cardiac 386 electrophysiology. These results were unexpected, based on what is known for common cancer mechanisms 387 such as mutations in receptor tyrosine kinases and GTPases. We would have expected that robust kinetic 388 parameters of gene products could have been associated with overrepresented regions of structural variation in 389 the genome associated with arrhythmias. In fact, others have even suggested that because of evolutionary 390 selection constraints, it is just as likely that most genes involved in common polymorphic rearrangements are 391 tolerant of changes in certain types of architectural variation (44). The power obtained by integration of 392 multiple mathematical approaches and human RNA sequencing has enabled us to obtain a counterintuitive and 393 deep understanding of genotype-phenotype relationships and improved our ability to predict disease risk. 394 The data from multiple modeling studies, human RNA sequencing as well as the experiments in the 395 zebrafish model together support the hypothesis that the genetic architecture of fragile electrophysiological 396 responses and arrhythmias is responsible for increased disease propensity. The self-organizing maps efficiently 397 classify many genes as fragile and demonstrate substantial enrichment for genomic regions associated with 398 cardiac electrical parameters over the remainder of the genome. This is a new approach that provides a 399 comprehensive framework for understanding how variations of a convergent phenotype may manifest from 400 multigene interactions. Similar to other multigenic disorders that were initially characterized as being 401 monogenic, pathophysiologies of cardiac electrical activity are likely to be caused, modulated or suppressed by 402 allelic heterogeneity and mutations at multiple loci that are associated with fragile kinetics (45). Further 403 mechanistic understanding of how the multiple genomic loci interact will always come from studies focused on 404 physical and functional interactions or regulation of the proteins involved. This study provides direct evidence 405 in support of this assertion. It should be noted that the partial least square based correlation approach between 406 kinetic parameters and genomic loci has its limitation in providing comprehensive mechanistic understanding. 407 Nevertheless defining such relationships provides the boundary conditions within which the mechanisms will 408 operate. 409 The network based approach for prediction of additional genomic loci and testing of the predictions in 410 humans and the zebrafish models indicates that there are likely to be additional genomic loci that are related to 411 the origins of arrhythmias and disease progression or that contribute to disease propensity in the context of other 412 genomic variations or environmental effects. A collaborative study of Noonan syndrome allowed one of us to 413 use a pathway based approach to identify a gene that turned out to be disease related upon subsequent 414 laboratory based analyses of patient samples (46) . Perhaps further studies on the genomes of patients with 415 arrhythmias could lead to the identification of additional genes involved in the pathophysiology of cardiac 416 electrophysiology and provide a basis for developing new drugs to treatment of arrhythmias. We suspect that 417 the novel relationships identified in this study between fragile kinetic parameters and architectural variation 418 could be a common theme for many diseases with common complex traits. For example, autism, schizophrenia, 419 epilepsy, Parkinson disease, Alzheimer disease, immunological disorders and emphysema, among others, have 420 all been shown to result from structural variation in the genomes of at least some patients (44). The challenge 421 will be to define kinetic parameters and identify models capable of recapitulating the relationship between 422 fragility in dynamics and genomic determinants as one cause in multiple complex diseases. binomial distribution and independence for probability of any gene belonging to any set. Gene enrichment 475 analysis and statistics were calculated using the Enrichr program previously described by Chen et al (28) . (d) 476 Overlap of gene enrichment terms comparing network models to human RNA sequencing. The statistically 477 significant gene enrichment terms were identified from the genes in human RNA sequencing and separately for 478 each individual arrhythmia or ECG network. The number of terms that overlap were calculated as a percentage. 
